Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Cost of Revenue (2016 - 2025)

Sensus Healthcare (SRTS) has 10 years of Cost of Revenue data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Cost of Revenue fell 57.02% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $13.9 million, up 61.75%, while the annual FY2024 figure was $17.4 million, 209.84% up from the prior year.
  • Cost of Revenue reached $1.5 million in Q3 2025 per SRTS's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $8.8 million in Q4 2024 and bottomed at -$3.8 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $2.3 million, with a median of $1.8 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: tumbled 386.0% in 2022, then surged 878100.0% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $1.3 million in 2021, then crashed by 386.0% to -$3.8 million in 2022, then soared by 99.97% to -$1000.0 in 2023, then soared by 878100.0% to $8.8 million in 2024, then plummeted by 82.38% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $1.5 million in Q3 2025, $1.4 million in Q2 2025, and $2.2 million in Q1 2025.